The experiments described in this proposal are directed toward understanding the mechanism by which """"""""viral protein U"""""""" (Vpu) mediates the exist of HIV-1 particles from cells. Dr. Panganiban's experiments described here are centered around the role of a novel cellular protein that interacts directly with Vpu in yeast, in vitro and in human cells. This novel cellular protein, """"""""U-binding protein (Ubp) is a member of a protein superfamily that includes the immunophilins and a class of serine/threonine phosphatases containing tetratrico-peptide repeats (TPRs). Dr. Panganiban and his colleagues have several complementary goals. They will carry out experiments to examine the interaction between Vpu and Ubp in more detail. In particular. In particular they will identify regions of the two proteins that are required for protein-protein interaction, isolate mutants that exhibit altered binding stability, and test the hypothesis that Vpu action is mediated via Ubp. Dr. Panganiban's preliminary data also indicated that Ubp interacts directly with Hiv-1 Gag protein in vitro, and with the capsid domain of HIV-1 Gag protein in human cells. Thus, he will identify the sites on Ubp and Gag that are required for this interaction. To examine the effect on Ubp on particle release, the effect of expression of wild type and mutant forms of Ubp and Gag that are required for this interaction. To examine the effect of Ubp on particle release, the effect of expression of wild type and mutant forms of Ubp on particle release will be determined. Similarly, they may determine whether ablation of endogenous Ubp expression affects the efficiency of particle release. Finally, since Ubp has not been previously characterized, Dr. Panganiban and his colleagues will examine the intrinsic properties of Ubp and try to gain insight into the normal role of Ubp in the cell. The overall goal of these studies to develop a comprehensive picture that accounts for the molecular mechanism by which Vpu mediates particle release.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA022443-22
Application #
6203034
Study Section
Project Start
1999-05-01
Project End
2000-04-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
22
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Weng, Chao; Lee, Denis; Gelbmann, Christopher B et al. (2018) Human Cytomegalovirus Productively Replicates In Vitro in Undifferentiated Oral Epithelial Cells. J Virol 92:
Bristol, Jillian A; Djavadian, Reza; Albright, Emily R et al. (2018) A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathog 14:e1007179
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
UmaƱa, Angie C; Iwahori, Satoko; Kalejta, Robert F (2018) Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk). ACS Chem Biol 13:189-199
Meyers, Jordan M; Grace, Miranda; Uberoi, Aayushi et al. (2018) Inhibition of TGF-? and NOTCH Signaling by Cutaneous Papillomaviruses. Front Microbiol 9:389
Uberoi, Aayushi; Yoshida, Satoshi; Lambert, Paul F (2018) Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1). J Virol Methods 253:11-17
Djavadian, Reza; Hayes, Mitchell; Johannsen, Eric (2018) CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms. PLoS Pathog 14:e1007114
Chakravorty, Adityarup; Sugden, Bill (2018) Long-distance communication: Looping of human papillomavirus genomes regulates expression of viral oncogenes. PLoS Biol 16:e3000062
Chiu, Ya-Fang; Sugden, Bill (2018) Plasmid Partitioning by Human Tumor Viruses. J Virol 92:
Shin, Myeong-Kyun; Payne, Susan N; Bilger, Andrea et al. (2018) Activating Mutations in Pik3caContribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes. Clin Cancer Res :

Showing the most recent 10 out of 434 publications